A mixture model approach in gene-gene and gene-environmental interactions for binary phenotypes.

PharmGKB: understanding the effects of individual genetic variants.

Cardiac sodium channel variants: action players with many faces.

Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations.

Copy-number analysis of topoisomerase and thymidylate synthase genes in frozen and FFPE DNAs of colorectal cancers.

Pharmacogenomics: candidate gene identification, functional validation and mechanisms.

Clinical predictors and outcomes of consistent bronchodilator response in the childhood asthma management program.

Characterization of low-density lipoprotein cholesterol-lowering efficacy for atorvastatin in a population-based DNA biorepository.

Screening and replication using the same data set: testing strategies for family-based studies in which all probands are affected.

Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Children's Oncology Group Study [corrected].

Beta-1-adrenoceptor genetic variants and ethnicity independently affect response to beta-blockade.

Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia.

Genetic variants associated with carboplatin-induced cytotoxicity in cell lines derived from Africans.

On the frequency of copy number variants.

Genes to diseases (G2D) computational method to identify asthma candidate genes.

Harnessing economic drivers for successful clinical implementation of pharmacogenetic testing.

Pharmacogenomics of endocrine therapy in breast cancer.

Breast cancer risk reduction and membrane-bound catechol O-methyltransferase genetic polymorphisms.

ARG1 is a novel bronchodilator response gene: screening and replication in four asthma cohorts.

beta-adrenergic receptor gene polymorphisms and beta-blocker treatment outcomes in hypertension.